Compounding errors

New England Journal of Medicine

Volumn 367, Issue 25, 2012, Pages 2436-2437

  Drazen, Jeffrey M ^a   Curfman, Gregory D ^a   Baden, Lindsey R ^a   Morrissey, Stephen ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPREDNISOLONE ACETATE;

BACKACHE; COMPOUNDING ERROR; DRUG CONTAMINATION; DRUG FORMULATION; DRUG INDICATION; DRUG MANUFACTURE; DRUG PACKAGING; DRUG SAFETY; EDITORIAL; ERROR; EXSEROHILUM ROSTRATUM; FOOD AND DRUG ADMINISTRATION; FUNGAL MENINGITIS; HUMAN; LAW; MOULD; PHARMACY; PRIORITY JOURNAL;

EID: 84871288105     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe1213569     Document Type: Editorial

References (7)

1. Pettit AC, Kropski JA, Castilho JL, et al. The index case for the fungal meningitis outbreak in the United States. N Engl J Med 2012;367:2119-25.
2. Kainer MA, Reagan DR, Nguyen DB, et al. Fungal infections associated with contaminated methylprednisolone in Tennessee. N Engl J Med 2012;367:2194-203.
3. Cohen SP, White RL, Kurihara C, et al. Epidural steroids, etanercept, or saline in subacute sciatica: a multicenter, randomized trial. Ann Intern Med 2012;156:551-9.
4. Staal JB, de Bie R, de Vet HC, et al. Injection therapy for subacute and chronic low-back pain. Cochrane Database Syst Rev 2008;3:CD001824.
5. Exophiala infection from contaminated injectable steroids prepared by a compounding pharmacy - United States, July-November 2002. MMWR Morb Mortal Wkly Rep 2002;51:1109-12.
6. Outterson K. Regulating compounding pharmacies after NECC. N Engl J Med 2012;367:1969-72.
7. Verifying Authority and Legality In Drug (VALID) Compounding Act of 2012. H.R. 6584.